Emerging Stocks Down Under 22 December 2020: Cann Group, Proteomics International, Senetas Corporation

Cann Group: Wait until 2022

In today’s edition of Emerging Stocks Down Under, 2020 has not been kind to the shareholders of the medicinal cannabis company Cann Group. On 20 January this stock was changing hands at $1.68 a share, whereas by 2 November it was down to 30 cents. Medicinal cannabis has been out of favour and this company is taking a bit longer to execute on its business plan. Therefore, we feel it is a two star story for now.

Also in today’s edition, a look at diagnostics developer Proteomics International (ASX: PIQ) and cybersecurity solutions developer the Senetas Corporation (ASX: SEN).

Get access to all editions through a 30-day FREE TRIAL. No credit card required and the trial expires automatically.

GET A 30-DAY FREE TRIAL

Click here to read the previous edition of Emerging Stocks Down Under published 15 December 2020

For in-depth research reports or to keep up-to-date on the latest Stocks Down Under news see our parent company, Pitt Street Research, or follow us on Facebook and Twitter